Rethinking treatment for RET-altered lung and thyroid cancers: selpercatinib approval by the EMA

Title
Rethinking treatment for RET-altered lung and thyroid cancers: selpercatinib approval by the EMA
Authors
Keywords
-
Journal
ESMO Open
Volume 6, Issue 1, Pages 100041
Publisher
Elsevier BV
Online
2021-01-19
DOI
10.1016/j.esmoop.2020.100041

Ask authors/readers for more resources

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started